Italy Nuclear Imaging Market Size, Share, and COVID-19 Impact Analysis, By Product (Equipment, Radioisotopes Including SPECT and PET Radioisotopes, and Other), By Application (Cardiology, Neurology, Thyroid, Oncology, Other), and Italy Nuclear Imaging Market Insights, Industry Trend, Forecasts to 2035

Italy Nuclear Imaging Market Insights Forecasts to 2035

• The Italy Nuclear Imaging Market Size Was Estimated at USD 285.75 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 7.3% from 2025 to 2035
• The Italy Nuclear Imaging Market Size is Expected to Reach USD 620 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Italy nuclear imaging market size is anticipated to reach USD 620 million by 2035, growing at a CAGR of 7.3% from 2025 to 2035. The Italy nuclear imaging market is driven by the rising prevalence of cancer and cardiovascular diseases, growing demand for early and accurate diagnostics, increasing adoption of hybrid imaging technologies, expanding geriatric population, and continuous investments in healthcare infrastructure and nuclear medicine facilities.

Market Overview

The Italy Nuclear Imaging Market Size refers to the use of advanced diagnostic techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to visualize metabolic and molecular activity within the body. These technologies are widely used in oncology, cardiology, and neurology for early disease detection and therapy monitoring. Market growth is supported by the rising incidence of cancer and cardiovascular disorders, an aging population, and increasing emphasis on early and precise diagnosis. Additionally, growing healthcare expenditure, improved reimbursement frameworks, and the expansion of nuclear medicine departments in hospitals are strengthening market development across Italy.

Technological advancement is a key pillar shaping the Italy Nuclear Imaging Market Size. Hybrid imaging systems such as PET/CT and SPECT/CT are increasingly adopted as they combine functional and anatomical imaging, delivering higher diagnostic accuracy and better clinical outcomes. Innovations in radiopharmaceuticals, including targeted tracers with improved specificity and reduced radiation exposure, are enhancing imaging effectiveness. Furthermore, digital detectors, AI-assisted image reconstruction, and automated workflows are improving scan speed, image clarity, and operational efficiency, allowing healthcare providers to manage higher patient volumes with optimized resources.

Several notable trends are influencing the market’s evolution. First, the growing adoption of hybrid imaging systems is improving diagnostic confidence and treatment planning. Second, the expansion of theranostics, which integrates diagnosis and targeted therapy, is gaining momentum, particularly in oncology care. Third, the integration of artificial intelligence in image analysis supports faster interpretation and reduced diagnostic errors. Fourth, increasing investment in nuclear medicine infrastructure and training is expanding access to advanced imaging services, especially in specialized and regional healthcare centers across Italy.

Report Coverage

This research report categorizes the market for the Italy Nuclear Imaging Market Size based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Italy nuclear imaging market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Italy nuclear imaging market.

Driving Factors

The Italy Nuclear Imaging Market Size is driven by the increasing prevalence of cancer, cardiovascular, and neurological disorders that require accurate and early-stage diagnosis. A rapidly aging population is raising demand for advanced diagnostic imaging. Growth is further supported by rising healthcare expenditure, expansion of nuclear medicine departments, and improved reimbursement policies. Technological advancements such as hybrid PET/CT systems and innovative radiopharmaceuticals enhance diagnostic precision, encouraging adoption across hospitals and diagnostic centers. Additionally, growing awareness of personalized medicine and theranostics is strengthening demand for nuclear imaging procedures.

Restraining Factors

The Italy Nuclear Imaging Market Size faces restraints due to the high cost of imaging equipment and radiopharmaceuticals, limiting adoption among smaller healthcare facilities. Strict regulatory requirements for radioactive materials, shortage of skilled nuclear medicine professionals, and concerns related to radiation exposure further slow installation rates and overall market expansion.

Market Segmentation

The Italy Nuclear Imaging Market share is classified into product and application.

• The equipment segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Italy Nuclear Imaging Market Size is segmented by product into equipment, radioisotopes including SPECT and PET radioisotopes, and other. Among these, the equipment segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The equipment segment dominates the market because PET/CT and SPECT/CT systems require high initial capital investment and contribute significantly to overall market value. Hospitals and diagnostic centers prioritize these systems to achieve higher diagnostic accuracy and support growing oncology and cardiology workloads. Additionally, replacement of aging scanners, adoption of hybrid imaging technologies, and government-backed modernization of healthcare infrastructure continue to drive sustained demand for advanced nuclear imaging equipment across Italy.

• The oncology segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Italy Nuclear Imaging Market Size is segmented by application into cardiology, neurology, thyroid, oncology, and other.  Among these, the oncology segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The oncology segment dominates the market due to the high prevalence of cancer and the critical role of PET and SPECT imaging in tumor detection, staging, and treatment monitoring. Nuclear imaging enables precise assessment of metabolic activity, supporting personalized therapy decisions. Widespread adoption of PET/CT in oncology centers, increasing use of radiotracers for specific cancers, and rising demand for early and accurate diagnosis further strengthen the leadership of this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Italy Nuclear Imaging Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Curium Pharma
• Cardinal Health
• Bracco Imaging S.p.A
• Other

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Italy, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Italy Nuclear Imaging Market Size based on the below-mentioned segments:

Italy Nuclear Imaging Market, By Product

• Equipment
• Radioisotopes Including SPECT and PET Radioisotopes
• Other

Italy Nuclear Imaging Market, By Application

• Cardiology
• Neurology
• Thyroid
• Oncology
• Other